The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Cardiovascular disease and mental illness commonly co-occur. Addressing them together can improve both mental health and ...

New research shows flood exposure increases hospitalisation risks for up to 7 months, affecting cardiovascular, metabolic, ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

A new study shows that colibactin exposure in the first decade imprints DNA changes that can accelerate colorectal cancer ...

Significant support and follow-up’ may be necessary for older patients to implement their care plans, according to a ...